Ciro Rodríguez

Mr. Ciro Rodríguez

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
FMFrancesco Millozzi
Francesco Millozzi
PMPaula Milán
Paula Milán
ARGHYA SETTARGHYA SETT
ARGHYA SETT
GCGiovanni Delli Carpini
Giovanni Delli Carpini
MBMarco De Bardi
Marco De Bardi
DGDaniela Palacios García
Daniela Palacios García
Inefficient targeting of muscle stem cells (MuSCs), also called satellite cells, represents a major bottleneck of current therapeutic strategies for muscular dystrophies, as it precludes the possibility of promoting compensatory regeneration. Here we describe a muscle-targeting delivery platform, based on gold nanoparticles, that enables the release of therapeutic oligonucleotides into MuSCs. We demonstrate that AuNPs conjugation to an aptamer against α7/β1 integrin dimers directs either local or systemic delivery of microRNA-206 to MuSCs, thereby promoting muscle regeneration and improving muscle functionality, in a mouse model of Duchenne Muscular Dystrophy. We show here that this platform is biocompatible, non-toxic, and non-immunogenic, and it can be easily adapted for the release of a wide range of therapeutic oligonucleotides into diseased muscles.

16 March 2022 in Talanta
Verified
Journal Article
Open access
CRCiro Rodríguez
Ciro Rodríguez
NLNuria Lafuente-Gómez
Nuria Lafuente-Gómez
CCCatarina Coutinho
Catarina Coutinho
DPDemián Pardo
Demián Pardo
HAHernán Alarcón-Iniesta
Hernán Alarcón-Iniesta
Álvaro SomozaÁlvaro Somoza
Álvaro Somoza
We present a fast, reliable and easy to scale-up colorimetric sensor based on gold nanoparticles (AuNPs) to detect the sequences coding for the RdRp, E, and S proteins of SARS-CoV-2. The optimization of the system (so-called “the sensor”) includes the evaluation of different sizes of nanoparticles, sequences of oligonucleotides and buffers. It is stable for months without any noticeable decrease in its activity, allowing the detection of SARS-CoV-2 sequences by the naked eye in 15 min. The efficiency and selectivity of detection, in terms of significative colorimetric changes in the solution upon target recognition, are qualitatively (visually) and quantitatively (absorbance measurements) assessed using synthetic samples and samples derived from infected cells and patients. Furthermore, an easy and affordable amplification approach is implemented to increase the system's sensitivity for detecting high and medium viral loads (≥103 - 104 viral RNA copies/μl) in patient samples. The whole process (amplification and detection) takes 2.5 h. Due to the ease of use, stability and minimum equipment requirements, the proposed approach can be a valuable tool for the detection of SARS-CoV-2 at facilities with limited resources.

10 July 2019 in Cancers
Verified
Journal Article
Open access
PDF file
ALAna Latorre
Ana Latorre
ALAlfonso Latorre
Alfonso Latorre
CMCastellanos Molina Milagros
Castellanos Molina Milagros
CRCiro Rodríguez
Ciro Rodríguez
ALAna Lazaro-Carrillo
Ana Lazaro-Carrillo
Álvaro SomozaÁlvaro Somoza
Álvaro Somoza
Controlled delivery of multiple chemotherapeutics can improve the effectiveness of treatments and reduce side effects and relapses. Here in, we used albumin-stabilized gold nanoclusters modified with doxorubicin and SN38 (AuNCs-DS) as combined therapy for cancer. The chemotherapeutics are conjugated to the nanostructures using linkers that release them when exposed to different internal stimuli (Glutathione and pH). This system has shown potent antitumor activity against breast and pancreatic cancer cells. Our studies indicate that the antineoplastic activity observed may be related to the reinforced DNA damage generated by the combination of the drugs. Moreover, this system presented antineoplastic activity against mammospheres, a culturing model for cancer stem cells, leading to an efficient reduction of the number of oncospheres and their size. In summary, the nanostructures reported here are promising carriers for combination therapy against cancer and particularly to cancer stem cells.

25 September 2018 in Biomimetics
Verified
Journal Article
Open access
PDF file
PMPaula Milán
Paula Milán
ALAlfonso Latorre
Alfonso Latorre
CRCiro Rodríguez
Ciro Rodríguez
ÁMÁlvaro Del Moral
Álvaro Del Moral
Álvaro SomozaÁlvaro Somoza
Álvaro Somoza
Uveal melanoma (UM) is the most common primary intraocular malignant tumor in adults and around half of the patients develop metastasis and die shortly after because of the lack of effective therapies for metastatic UM. Consequently, new therapeutic approaches to this disease are welcome. In this regard, microRNAs have been shown to have a key role in neoplasia progression and have the potential to be used as therapeutic tools. In addition, in different cancers including UM, a particular microRNA signature appears that is different from healthy cells. Thus, restoring the regular levels of microRNAs could restore the normal behavior of cells. In this study, four microRNAs downregulated in UM have been chosen to reprogram cancer cells, to promote cell death or increase their sensitivity to the chemotherapeutic SN38. Furthermore, to improve the internalization, stability and/or solubility of the therapeutic molecules employed in this approach, gold nanoparticles (AuNPs) were used as carriers. Remarkably, this study found a synergistic effect when the four oligonucleotides were employed and when the chemotherapeutic drug was added.

4 October 2019 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
LOLaura Ortiz‐Rojano
Laura Ortiz‐Rojano
JRJaime Rojas‐Martín
Jaime Rojas‐Martín
CRCiro Rodríguez
Ciro Rodríguez
MCM. Carmen Carreño
M. Carmen Carreño
MRMaría Ribagorda
María Ribagorda

7 December 2021 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
NLNuria Lafuente-Gómez
Nuria Lafuente-Gómez
ALAna Latorre
Ana Latorre
PMPaula Milán
Paula Milán
CRCiro Rodríguez
Ciro Rodríguez
Álvaro SomozaÁlvaro Somoza
Álvaro Somoza
This comprehensive feature article summarizes the recent progress of controlled release systems based on nanostructures for cancer treatment.